Vascular Access

Hemodialysis patients are connected to life by means of vascular access. The complications of vascular access represent one of the most important causes of morbidity, mortality and high healthcare costs in the hemodialysis patients. Although it is known that the best vascular access is AVF, the fistula use rate is still low in most countries. This review will examine; association of various vascular access with morbidity, mortality and dialysis costs; different practice patterns in the world and reasons of this; finally, solutions for vascular access problems

Outcome of Renal Transplantation in Patients With Diabetes Mellitus: A Single - Center Experience

WOS: 000491488703295

Management of Patients with a Failed Kidney Transplant

WOS: 000417359300002The number of patients with a failed allograft returning to dialysis increases over time. These patients have increased morbidity and mortality compared with their transplant-naive, incident dialysis patients. The management of these patients is more difficult as many issues are unclear. This review includes the current suggestions on mortality, dialysis reinitiation time, renal replacement therapy, and retransplantation. We aimed to reach a conclusion regarding these issues

Management of Patients with a Failed Kidney Transplant

The number of patients with a failed allograft returning to dialysis increases over time. These patients have increased morbidity and mortality compared with their transplant-naive, incident dialysis patients. The management of these patients is more difficult as many issues are unclear. This review includes the current suggestions on mortality, dialysis reinitiation time, renal replacement therapy, and retransplantation. We aimed to reach a conclusion regarding these issues

Outcomes of renal transplants from spousal donors: 25 years of experience at our center

Objectives: Many transplantation teams have attempted renal transplants from living unrelated kidney donors, as well as from cadaveric and living related kidney donors. In this study, we evaluated the results for renal transplants from spousal donors at our center

Effects of arteriovenous fistula on clinical, laboratory and echocardiographic findings in renal allograft recipients

Purpose: Left ventricular hypertrophy (LVH) is frequently observed in patients with end-stage renal disease and renal allograft recipients, and is an independent and strong predictor of morbidity and mortality. Presence of a patent arteriovenous fistula (AVF) after renal transplantation may contribute to the persistent LVH. We investigated the clinical, laboratory, and echocardiographic findings in patients with renal transplants with or without AVF

Effects of arteriovenous fistula on clinical, laboratory and echocardiographic findings in renal allograft recipients

Purpose: Left ventricular hypertrophy (LVH) is frequently observed in patients with end-stage renal disease and renal allograft recipients, and is an independent and strong predictor of morbidity and mortality. Presence of a patent arteriovenous fistula (AVF) after renal transplantation may contribute to the persistent LVH. We investigated the clinical, laboratory, and echocardiographic findings in patients with renal transplants with or without AVF

Does pregnancy increase graft loss in female renal allograft recipients?

Although many transplanted women who were previously infertile can conceive during the posttransplant period, maternal and fetal complications are likely. We evaluated the effect of pregnancy after renal transplantation in this study